HARP - Harpoon Therapeutics EPS misses by $0.06 misses on revenue March, 12 2020 04:13 PM Harpoon Therapeutics Inc. Harpoon Therapeutics (NASDAQ:HARP): Q4 GAAP EPS of -$0.58 misses by $0.06.More news on: Harpoon Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...